Introduction
Celiac disease is a gluten-sensitive enteropathy previously referred to as "sprue" (ICD-10: K90.0). It represents a chronic immune-mediated disorder of the mucous membrane of the small intestine. Gluten peptides (alcohol-soluble gluten fractions, so-called gliadins) found in cereals (wheat, rye, barley and spelt) and related prolamins serve are triggers leading to celiac onset in genetically predisposed individuals [1, 2, 3] . Whilst the disorder o en used to be referred to as celiac disease in children, the term "celiac sprue" is used for adults. According to the more recent nomenclature, the term celiac disease should be used for all age groups. In the broad spectrum of varying etiologies of food intolerance, celiac disease represents a distinct immune-mediated entity (Fig. 1) . From an historical perspective, celiac disease was initially believed to be a malabsorption disorder, only later being interpreted as a hypersensitivity reaction in type-IV allergy to wheat or its constituents. Finally, a er gaining a precise understanding of its pathogenesis on the basis of the characteristic production of transglutaminase (TG) antibodies, it is classi ed today as an autoimmune reaction [1, 2, 3] .
e prevalence of celiac disease is subject to wide geographical variation, reaching 1:500 in Germany, for example, whereby women are more commonly a ected than men. At the same time, it is assumed that the disorder is diagnosed in only 10 %-20 % of a ected individuals (the so-called iceberg phenomenon). Virtually all individuals su ering from celiac disease carry one of the two human leukocyte antigen (HLA) subtypes DQ2 or DQ8. A number of diseases frequently occur in association with celiac disease: autoimmune diseases such as autoimmune thyroiditis (10 %-20 %), lactose malabsorption (20 %-30 %, o en also as a result of villous atrophy), type-1 diabetes mellitus (2 %-7 %), selective immunoglobulin (Ig)-A de ciency (3 %-10 %), Turner syndrome (8 %) and Down's syndrome (7 %).
Pathogenesis of celiac disease
Gluten peptides (gliadin fraction) are taken up via the mucous membrane of the small intestine and deamidated by tissue transglutaminase. e complexes formed by tissue transglutaminase and the modi ed gliadin are taken up by DQ2+ and DQ8+ antigen-processing cells and presented to CD4+ helper cells via the major histocompatibility complex (MHC) class-II receptor complex [1, 2, 3] . Following activation, these T-helper cells stimulate cytotoxic CD8+ lymphocytes (e.g., intraepithelial lymphocytes) by means of increasingly expressed 1 cytokines (interleukin 2, 6 and γ-Interferon) on the one hand, and B-lymphocytes via 2 cytokines (interleukin 4, 5, 10) on the other. is results in cytotoxic and antibody-mediated mechanisms as well as broblast activation (matrix metalloproteinase secretion), which together lead to epithelial damage, in ammatory cell in ltration of the lamina propria and ultimately to varying degrees of villous atrophy [2, 3, 4, 5] . Florid immune responses result in lesions characteristic of celiac disease, such as increased intraepithelial lymphocytes (> 25 lymphocytes/100 epithelial cells), crypt hyperplasia and partial or total villous atrophy [2] .
Celiac disease-like symptoms and di erential diagnosis Independent of this clearly de ned pathogenetic disease mechanism of celiac disease, there is currently evidence that gastrointestinal symptoms re- sulting from gluten exposure can also be provoked in patients who, for the most part, are not genetically predisposed by HLA-DQ2 and/or HLA-DQ8 (referred to as non-celiac disease gluten intolerance) [5] . In contrast to celiac disease, interleukin-6 expression levels in gastric tissue, which, among others things, amplify the mucosal in ammatory reaction in celiac disease, are not elevated in this setting. To what extent local intestinal IgE antibodies (local type-1 allergy), local cellular allergic responses to food (local type-IV allergy) or other non-immunological mechanisms play a role here in patients with symptoms of irritable bowel syndrome or food intolerance is currently unclear [4, 6, 7, 8, 9 , 10] (Tab. 1).
Abbreviations
Schuppan et al. discuss the involvement of α-amylase/trypsin inhibitors, components of wheat, which, by activating the Toll-like receptor-4 (TLR4), contribute to the mediation of in ammation in both celiac disease and non-celiac disease patients. Animal models have shown that mice in which the TLR4 gene has been switched o do not respond to oral provocation with α-amylase/trypsin inhibitors with a systemic in ammatory response [11] .
In addition to systemic or locally detectable allergic responses to wheat allergens, a variety of non-immunological mecha-nisms also need to be considered in the di erential diagnosis of patients with wheat or cereal intolerance. In this context, ruling out fructan-induced abdominal symptoms plays an important role in TG-IgA-negative patients, for example, since it is precisely wheatbased foodstu s containing fructo-oligo-or polysaccharides that cannot be digested, are osmotically active and can cause symptoms of irritable bowel syndrome [10] . Small intestinal bacterial overgrowth, which leads to increased bacterial proliferation following food intake [8, 10, 12, 13] , can also cause abdominal symptoms following cereal ingestion. Small intestinal bacterial overgrowth may be associated with intolerance to simple (e. g., fructose) and complex carbohydrates (e. g., starch, fructose polymers).
e term gluten sensitivity is sometimes used for those patients who, despite celiac disease-like symptoms, show no TG-IgA antibodies [14] .
Clinical picture of celiac disease
Celiac disease was long considered a pediatric syndrome with the typical combination of symptoms comprising diarrhea, steatorrhea, malabsorption and failure to thrive. More recently, however, an increasing number of adults and elderly individuals have also been diagnosed with celiac disease, the clinical spectrum of the disease has expanded and the clinical picture has altered [2, 3, 4, 5, 8, 13, 15, 16]. It is assumed that only around 10 %-40 % of affected patients exhibit typical symptoms (see also "Classic celiac disease with typical symptoms") [1, 2, 3, 12, 13, 15] . Today, more than 50 % of patients present with atypical symptoms such as anemia, iron de ciency without anemia, abdominal pain, psychiatric symptoms like mood swings, skin lesions, osteoporosis, loss of appetite and growth retardation. Dermatitis herpetiformis (Duhring's disease), depression, gluten-sensitive ataxia or spontaneous abortion [12, 13, 15, 16] are seen more rarely.
The various forms of celiac disease
A distinction is made between seven clinical forms of celiac disease (formerly sprue) on the basis of phenotype and clinical course; these forms are discussed below.
Classic celiac disease with typical symptoms
Classic symptoms include diarrhea, weight loss, malabsorption disorders, primarily in infants or small children (aged 1-5 years), o en associated with failure to thrive, growth retardation, and endocrine disorders [1, 2, 3, 6, 12] . is form becomes less common with increasing age. 
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Atypical celiac disease (oligo-or monosymptomatic)
Gastrointestinal symptoms are completely absent in approximately 40 % of a ected individuals (adults) [6, 15, 16] . Relevant extraintestinal manifestations include, among many others: -Anemia (iron de ciency) -Osteoporosis -Chronically elevated transaminases -Atrophic and erythematous tongue -Arthritis -Psychiatric and neurological disorders (depressive episodes) -Chronic fatigue e erythemas, plaques and herpetiform blisters characteristic of dermatitis herpetiformis and sometimes mistaken for skin manifestations of food allergy occur in 5%-10% of all celiac disease patients as an extraintestinal symptom. E orescences are most commonly found on the extensor sides of the extremities.
Asymptomatic celiac disease (silent celiac disease)
Positive antibody ndings, HLA-DQ2 and/or -DQ8 positivity and pathological small intestine biopsy in the absence of dis-ease symptoms is referred to as asymptomatic celiac disease [6, 12, 16, 17, 18, 19] .
is particular form is o en diagnosed incidentally and, from a histological perspective, responds well and promptly to gluten abstention. However, the symptom-free patient o en primarily lacks the understanding needed to adhere to a diet and requires information and training. Abstention from gluten nevertheless has the potential to prevent the longterm complications of celiac disease (e.g., enteropathy-associated T-cell lymphoma).
Latent celiac disease
Here again, the patient is symptom-free -or virtually so -at the time of examination. In contrast to the above-mentioned asymptomatic or silent disease, however, the patient history suggests manifest celiac disease in the past (di erential diag-nosis: other diseases), the typical HLA-DQ2 or -DQ8 positivity-related manifestations of which have (evidently) regressed over the further disease course [6, 12, 16, 19] . Serological changes in latent celiac disease are o en borderline or con icting (negative), whilst histology is normal.
As in asymptomatic celiac disease, it remains unclear whether a conscious or unconscious modi cation in diet or other associated immune changes are responsible for the absence of disease manifestation or its regression.
Potential celiac disease
Potential celiac disease is diagnosed in patients with a positive antibody test and typical HLA constellation but negative small intestine biopsy. Despite normal histology, patients may have asymptomatic or oligosymptomatic disease and do not always develop histologically detectable celiac disease in the long term; nevertheless, this patient group generally responds well to a gluten-free diet [6, 12, 15, 16] .
Forms of celiac disease refractory to therapy
Celiac disease refractory to therapy is predominantly seen in the classic and atypical forms, where no su cient response to a gluten-free diet can be achieved despite positive serology and also usually characteristic histology. In fact, in rare cases, dis-ease progression is observed in spite of diet and is accompanied by increased in ammatory activity, the formation of subepithelial collagen bands beneath the intestinal epithelium (collagen celiac disease) and increased malabsorption [3, 15, 16, 20] . It is unclear in this context whether the disease, in the presence of a normal T-cell phenotype, is further triggered by incomplete gluten abstention (compliance), whether other infectious antigens are having a pathogenetic e ect, whether related gastrointestinal allergies are present (e.g. gluten substitutes, lupin our, corn) or whether, in the presence of aberrant T-cell populations (possibly malignant mutations), an autonomous dysfunction of the intestinal immune system already moving in the direction of lymphoma development has occurred [1, 16, 17, 18, 19, 20, 21] . At all events, in the case of celiac disease refractory to therapy or collagen celiac disease, classic dietary interventions are inadequate, making it necessary to take recourse to immunosuppressive approaches, such as systemic or local glucocorticoids, azathioprine or, in particularly refractory cases, anti-tumor necrosis factor (TNF) antibodies. In the literature, therapy-refractory celiac disease is divided into two subtypes according to the intraepithelial lymphocyte phenotype: subtype II is made distinct from subtype I by the loss of normal surface markers (CD3, CD4, CD8), as well as T-cell receptor chain rearrangement. e likelihood is greater in subtype I that, by intensifying treatment as described above, symptoms will improve. e prognosis for subtype II, however, remains poor [22] .
Early-onset celiac disease, seronegative form or presence of a potential di erential diagnosis
Early-onset or seronegative disease is assumed in patients exhibiting typical symptoms of celiac disease and a prompt re-sponse to a gluten-free diet. However, it is possible that serology is initially negative with this disease variant, since the disease process is at an early stage (e.g., onset following a viral or bacterial infection), making repeat serological tests over a 3-month period and HLA typing advisable [4, 6, 16] . From a di erential diagnostic perspective, a seronegative local form of celiac disease should be considered (local transglutaminase-IgA immune response) and needs to be sought using special diagnostic procedures or clinical provocation with an adequate volume of gluten [17, 18, 19] .
Other relevant di erential diagnoses of this early form of celiac disease, as shown in Tab. 1 [5, 7, 9, 18] , can imitate celiac disease clinically and often represent a signi cant diagnostic challenge in routine clinical practice: although patients report recurrent symptoms following the ingestion of bread, wheat products or products containing cereals, the disease cannot be con rmed by celiac disease diagnosis. It is important here to identify in particular those patients with wheat proteinmediated food allergy who exhibit speci c IgE antibodies to wheat pollen/ our, gliadin, gluten or exhibit other cereal types systemically (seropositive) or locally (seronegative) and who can develop the same clinical picture as celiac disease [4, 6, 7, 17, 19] .
Complications seen in the various celiac disease forms
In addition to the macronutrient loss caused by malassimilation (maldigestion and malabsorption), unidenti ed celiac dis-ease can cause weight loss, endocrine disorders (amenorrhea, osteoporosis, etc.), micronutrient loss accompanied by de cits due to iron, zinc, magnesium and selenium loss, etc. or vitamin de ciency (e. g., folic acid, vitamin B12, vitamin E) [6, 16] . is leads to further disease symptoms and complications, which may prompt patients to seek advice from specialized medical elds other than gastroenterology (e.g., endocrinology, neurology), such that relevant laboratory values and related symptoms should give rise to a careful consideration of celiac disease in the di erential diagnosis. Rare complications include the development of gastrointestinal ulcers, which in turn increase the risk of hemorrhage, perforation or structure forma-tion. In addition, patients with various forms of celiac disease exhibit an increased risk for the development of enteropathy-associated T-cell lymphoma of the small intestine [1, 2, 6, 20] , which has a considerable e ect on the prognosis of this otherwise e ectively treatable disease. However, there are a number of other rare complications seen in undetected celiac disease, such as the development of "brown bowel" syndrome due to severe vitamin E de ciency [3, 16, 21] , and dysregulation of epithelial DNA repair genes depending on the duration and degree of intestinal in ammation [23] , which in turn bears the further risk of causing epithelial neoplasms.
Rational diagnosis of celiac disease
Bearing in mind the high percentage of undiagnosed celiac disease patients (the "iceberg" phenomenon) and the broad spectrum of clinical manifestations, including oligosymptomatic or atypical disease forms, it becomes clear that following the appropriate and reliable diagnostic steps is essential in order to reach the diagnosis of celiac disease and improve its long-term prognosis.
As a general rule, laboratory investigations (serology and HLA diagnosis), transabdominal ultrasound, endoscopy and histology are principally used in addition to compiling a thorough patient history. Characteristic abnormalities are presented in Tab. 2, whereby in general, transglutaminase serology and/or histological classi cation (the gold standard) according to the Marsh criteria are used to con rm the diagnosis in the majority of patients today [1, 2, 3, 24, 25, 26] . Further techniques to examine the 4-to 6-m long small intestine are only necessary in the case of very particular diagnostic questions (see below: capsule endoscopy, balloon enteroscopy, magnetic resonance imaging [MRI] according to Sellink, etc).
It is important to establish from the patient history whether the individual has already undertaken self-initiated wheat or gluten abstention or reduction. is signi cantly in uences the sensitivity of the available tests [1, 2, 3, 16, 24, 25, 26] . erefore, where symptoms permit, the German Coeliac Society (Deutsche Gesellscha für Zölia-kie, DGZ) recommends exposure with at least 20 g gluten (two to four pieces of bread per day) for at least 1 month in order to identify the clinical picture conclusively [1, 2, 3, 8, 13, 15] . Failure to reach this exposure volume produces the risk of falsenegative results; thus, in equivocal cases, a standardized gluten exposure test is sometimes necessary in order to document immune phenomena for the purposes of con rming the diagnosis. Since gluten provocation is not possible -or desired -in patients with severe disease, a variety of other diagnostic strategies are o en used in clinical routine; these, however, o er lower diagnostic accuracy. In such cases, testing endoscopic biopsies with the in vitro gliadin challenge may o er a signi cant advantage to previous diagnostic approaches in the future, as evidenced by Tortora et al. who were able to show high diagnostic accuracy for the detection or exclusion of celiac disease by determining HLA-DR in biopsies [18, 19] .
According to the criteria of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), and in addition to the above-mentioned criteria, serological diagnosis (primarily transglutaminase, the most sensitive and speci c test available today) and/or histological con rmation of the diagnosis as well as remission under a gluten-free diet are also required [24] .
Serology
Given the availability of more speci c serological methods to detect celiac disease-induced antibodies (Tab. 3), the necessity for endoscopy with histological con rmation of the diagnosis has increasingly come under critical scrutiny in the various disease groups (children < 2 years, children > 2 years, adults; symptomatic/asymptomatic patients, positive or negative tissue transglutaminase antibodies, etc.) [15, 19, 24] . us, due to the costs of endoscopy and histology, as well as their comparatively high invasiveness (particularly in children), there is controversy regarding the need for biopsy to con rm the diagnosis of celiac disease. For this reason, a different approach is taken in children compared with adults, in part since the increased risk of malignancy with age in the latter age group in particular supports the need for endoscopic screening.
Several authors, however, recommend in general a risk-adapted approach tailored to the individual situation, age group, symptoms and diet. Performing screening in all asymptomatic patients o ers less promise and fewer cost bene ts than initiating primary diagnosis using serological tests in the case of even slight clinical suspicion or the presence or a celiac disease-related disorder (Tab. 3).
Appropriate serological tests include the detection of IgA antibodies to: -Anti-tissue transglutaminase type-2 IgA (anti-TG2-IgA) antibodies; the autoantigen of the antiendomysial antibodies) -Endomysium (antiendomysium-IgA antibodies, EMA-IgA) -Gliadin Having said that, antibodies to deamidated gliadin peptide (DGP) are considered to be signi cantly more reliable today than the conventional antibodies to anti-gliadin antibodies (AGA) o en tested in the past.
With the anti-TG2-IgA antibodies to be used rst, a primary sensitivity and speci city of 95 %-98 % is achieved in IgA-immunocompetent patients where adequate gluten intake and a two-to three-fold increase in the antibody titer compared to normal values are present and comorbidities are absent [12, 15, 24] . Since there are frequent variations from the above-mentioned status in clinical practice and false-low anti-TG titers may occur (e.g., viral infections, immune suppression), a combination of the rst two antibody fractions mentioned in Tab. 3 is recommended in order to increase sensitivity and speci city [4, 12, 19, 24] . us, in the case of reasonable suspicion, in individuals reporting cereal intolerance or in the presence of a related underlying disease, diagnostic measures to identify celiac disease can be initiated in IgA-immunocompetent individuals. High TG2 antibody titers are predictive of damage to the small intestine mucosa that can be reliably evidenced histologically [24, 26, 27] . However, false-positive TG2 antibodies are also found in Down's syndrome, other autoimmune diseases or neoplasia, liver disease, psoriasis or following Epstein-Barr virus (EBV) infection. erefore, a second, con rmatory test involving EMA detection should be performed in the case of positive TG titers.
e same recommendation regarding antibody diagnosis is made when abnormal small intestine histology showing signs of the Marsh classi cation is incidentally found on endoscopy/histology in individuals lacking typical symptoms. However, it should be borne in mind here that all Marsh stages, ranging from elevated intraepithelial lymphocytes to complete villous atrophy, can all be seen in other diseases (e.g., gastrointestinal allergies, autoimmune enteropathy, infections such as Giardia lamblia and in recipients of allogenic stem-cell trans- [1, 3, 20, 24, 26, 27] . e term autoimmune enteropathy is applied to those cases in which histological ndings falling within the Marsh classi cation are caused by antibodies against enterocytes. ese heterogenous manifestations, seen more commonly in children than in adults, have not been overly accessible to systematic research to date [28] . It is of elementary importance to consider the patient's IgA status when performing serology, since the above-mentioned IgA-based antibody tests can be negative in the case of IgA de ciency (5 %-10 % of celiac disease patients) [1, 4, 12, 19, 24] . In such cases, the same antibody tests for IgG should be used (Tab. 3), although these do not have quite the same sensitivity and speci city as IgAbased tests.
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The D-xylose test (25 g D-xylose administered orally with fl uids), which is no longer used routinely in primary diagnosis, generally only helps identify malabsorption in the jejunum if less than 4 g of the xylose administered is measured in urine after a 5-h test period, assuming kidney function is normal. This test has low specifi city and is not suited to establishing a celiac disease-specifi c diagnosis. However, it can be used as a quantitative measure of the jejunum's absorptive capacity during disease follow-up in
Determining HLA class as part of the diagnosis of celiac disease should be carried out secondary to the above-mentioned antibody testing using anti-TG2 and/or EMA antibodies, since it is not necessary in the case of typical symptoms and positive serology and histology, but rather only when the latter two are equivocal. Genetic testing for HLA-DQ2 or -DQ8 is only useful in the case of normal small intestine histology but positive or borderline antibody ndings, since virtually all celiac disease patients test positive for one of these two markers [3, 5, 16, 24] . Even if IgA-and/or IgGbased celiac disease serology is negative, HLA typing can yield valuable information on disease predisposition: in rare cases, combined IgA and IgG antibody defects, intestinal protein loss with reduced antibody levels or other variables that intervene with serology can make serological diagnosis challenging.
e ESPGHAN recently indicated that endoscopic histology can be dispensed with in children and adolescents due to the highly sensitive anti-TG2 antibodies in the presence of highly signicantly raised anti-TG2 antibody levels (> 10 times the normal level), HLA-DQ2 or DQ8 positivity and/or con rmatory EMA or DGP [24] . Since TG2 antibody production is subject to variation in children under 2 years, the detection of IgG antibodies to deamidated gliadin peptide, a test that supports diagnosis in this age group, should be used instead.
Whilst the advantage of celiac disease-based antibody testing lies in its low invasiveness, it should always been borne in mind along the diagnostic pathway that gluten abstention should only be prescribed following completion of diagnosis, and that diagnosis in children and adolescents based on serology and HLA determination can only be is established through signi cantly elevated antibody titers combined with other conclusive ndings (HLA positivity, second positive antibody nd-ings). In all other cases, as well as in adults, endoscopic histology remains an integral part of the diagnostic procedure. Moreover, other gastroenterological diseases (e. g., gastritis, enteritis, ulcers, neoplasia) need to be ruled out most particularly in symptomatic adults.
Endoscopy and histology (Marsh criteria)
Endoscopic examination, primarily by means of esophagogastroduodenoscopy, combined with small intestine biopsy and the above-mentioned serological criteria represent the gold standard for diagnosis in adults. Biopsies are evaluated according to the Marsh criteria (intraepithelial lymphocyte in ltration, crypt hyperplasia, villous atrophy) (Tab. 4). Histological diagnosis shows poorer interobserver variation than an overall consideration of serology, symptoms, remission on abstention and biopsy together [7, 24] . Histological classi cation of a Marsch-1 lesion is insu cient to support the diagnosis of celiac disease, since bacterial or viral infections, gastrointestinal allergies as well as other diseases may also be present in this setting. In equivocal cases, particularly where Marsch-1 or -2 classi cations are established, it is sometimes helpful to consult a second pathologist in order to broaden the spectrum of histological analysis, by means of special immunohistochemistry to quantify eosinophils and mast cells or to characterize lymphocytes, in order to review the di erential diagnoses discussed above and identify other diseases [7, 9, 18, 25] .
Deep small-intestine endoscopy using balloon enteroscopy or capsule endoscopy is used in particularly challenging cases, whereby balloon enteroscopy o ers the added advantage of obtaining tissue specimens from the deep small intestine for histology or functional biopsy testing and of performing endoscopically-guided segmental lavage to detect intestinal IgE antibodies [16, 17, 18, 19, 27, 29] . In this way, it is possible to localize and identify rarer di erential diagnoses such as intestinal mastocytosis, eosinophilic gastroenteritis, areas of extensive lymphofollicular hyperplasia and lymphoma disease.
Capsule endoscopy should only be used when enteroscopy is not possible or when distal segments of the intestine inaccessible with endoscopy need to be evaluated. At present, its diagnostic sensitivity remains limited by its lack of controllability and inability to obtain biopsy specimens; as such, it is only suited to visualizing the small intestinal mucosa, typical celiac disease lesions and other lesions or complications, as well as documenting the localization of a ected intestinal segments [12, 30] . In particular, capsule endoscopywhilst less invasive than balloon enteroscopynevertheless appears to provide a good visual overview of the length of the a ected mucosal segment due to its ability to visualize the entire intestinal tract. However, since capsule endoscopy as a purely diagnostic procedure lacks conclusive histology, its macroscopic evaluation is prone to misinterpretation, technical artefacts in image transmission, as well as motion and impurity artefacts, etc., which explains the lack of correlation between the extent of lesions seen on capsule endoscopy and clinical presentation [31] .
Transabdominal ultrasound
Transabdominal ultrasound's relevance in primary medical diagnosis is based on its non-invasive ability under good so-nographic conditions to rapidly visualize important abdominal organs and identify pathological organ changes in symptomatic patients (e. g., space-occupying lesions, chronic pancreatitis). However, abdominal ultrasound does not play a con rmatory role in the primary diagnosis of celiac disease, since clinically manifest celiac disease generally exhibits nonspeci c ndings, such as intestinal wall thickening (e.g., hypoechoic), uid-lled intestinal loops and thickened wall, perfusion changes as well as to and fro peristalsis ("washingmachine phenomenon"). Moreover, there is high interobserver variability and numerous other di erential diagnoses may produce a similar clinical picture (e. g., infectious gastroenteritis, Crohn's disease).
Once the diagnosis of celiac disease has been established, ultrasound -much like other non-invasive tests (e. g., b-D-xylose or 13C sorbitol breath tests) -can be used for follow-up investigations [16, 20, 32, 33] , since the parameters mentioned above can be quanti ed over time and a response to treatment recognized in the form of, e.g., reduced intestinal wall thickening.
Basic principles of the therapeutic approaches in celiac disease
At present, strict lifelong abstention from gluten represents the only de nitive therapy for celiac disease [1, 2, 3, 4, 5, 29] . is is particularly valid for patients with classic oligosymptomatic and atypical forms of the disease. Results for the other celiac disease forms [e.g., asymptomatic (silent) or latent] are inconsistent. Nevertheless, in equivocal cases, it is preferable to aim for or discuss lifelong gluten abstention with patients, since latent in ammatory changes in the gastrointestinal tract can persist even in an asymptomatic course, possibly leading to complications only a er a number of years [20, 21, 23, 25] .
Successful gluten abstention depends on adequate patient training aimed at instilling an understanding of the recurrence of celiac disease following dietary mistakes, checking food ingredients and using gluten-free food substitutes. Spelt, while com-monly considered an alternative in known celiac disease, also contains gluten and, as such, does not represent an alternative foodstu .
e most important aspects of gluten-free nutri- Gluten-free foodstu s are de ned as nutritional substances that contain less than 20 mg gluten per kilogram, whilst low-gluten foodstu s can contain 20-100 mg/kg. Celiac disease patients o en perceive their health and sense of well-being as signicantly improved upon gluten abstention, whereas the rationale and purpose of gluten abstention in asymptomatic patients is frequently questioned and inconclusively established [6, 16, 34] . In the case of manifest malabsorption resulting from symptomatic celiac disease, other aspects of nutrition o en need to be discussed with the patient in the rst instance, since mineral, electrolyte, iron, and vitamin de ciencies may appear due to damage to the small intestine and require targeted substitution [9, 16, 21] . In addition, other secondary food intolerances, such as lactase de ciency, fructose malabsorption or intolerance of histamine-rich foods, need to be considered when compiling a dietary plan. In cases of severe malabsorption or therapy-refractory disease, pancreas enzymes and the administra-tion of glucocorticoids or immunosuppressants, such as azathioprine or cyclosporin, are occasionally necessary alongside gluten abstention and nutritional therapy [16, 20, 32, 34] .
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Novel strategies could potentially simplify the management of celiac disease in the future. ese include the use of bacterial endopeptidases to breakdown ingested gluten. Genetically modi ed and hence gluten-free cereal types as well as other immunomodulatory measures to strengthen the anti-in ammatory immune response may gain in importance in the future [3, 32] .
To what extent probiotic preparations -by modulating regulatory T cells, changing the intestinal humoral immune response to attenuate anti-TG2 or anti-DGP-IgA antibody secretion or stimulate tolerance mechanisms or protective cytokines and, lastly, by using the capacity of certain bacterial strains to hydrolyze gliadin polypeptides -represent a relevant therapy option in celiac disease is currently the subject of intense research [1, 3, 32, 35, 36] . Table 5 Basic principles of gluten-free nutrition in celiac disease
Permitted Permitted
Prohibited Prohibited Corn, rice, millet Buckwheat, oats (up to 2 g/kg BW) Lupin fl our Pulses (e. g. lentils, soy) Vegetables (e.g. lettuce, cucumber, tomatoes) Meat Poultry Fish Wheat, rye, barley Candied products Malt coff ee, beer, drinks made from the above types of cereal Chocolates, malt confectionary, desserts, marzipan, potato chips, ready-to-eat potato products, vegetable stock Fruit preparations, fruit concentrates, baking ingredients Ketchup, mustard Check ready meals with additives carefully e.g. cheese and sausage products, milk products, sauces, fi llings
